PHVS
USDPharvaris N.V. Ordinary Shares
$21.640-0.842 (-3.746%)
Real-time Price
Healthcare
Biotechnology
Switzerland
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$22.482
High
$22.482
Low
$21.585
Volume
0.14M
Company Fundamentals
Market Cap
1.4B
Industry
Biotechnology
Country
Switzerland
Trading Stats
Avg Volume
0.19M
Exchange
NMS
Currency
USD
52-Week Range
Low $11.51Current $21.640High $26.33
Related News
GlobeNewswire
Pharvaris to Present Clinical Data at the ACAAI 2025 Annual Scientific Meeting
ZUG, Switzerland, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Pharvaris (NASDAQ:PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living
View more
Analyst Upgrades
HC Wainwright & Co. Initiates Coverage On Pharvaris with Buy Rating, Announces Price Target of $60
HC Wainwright & Co. analyst Patrick R. Trucchio initiates coverage on Pharvaris with a Buy rating and announces Price Target of $60.
View more
Analyst Upgrades
B of A Securities Upgrades Pharvaris to Neutral, Raises Price Target to $27
B of A Securities analyst Tazeen Ahmad upgrades Pharvaris from Underperform to Neutral and raises the price target from $16 to $27.
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.